what is happening?.... Why keep the shares going down?
(I hear the results of Q1 are trading in the right way, so I wonder what else is going on)
13 replies (most recent on top)
August will pass and the stock will be in the toliet due to the profitability of the business and how it’s run. Thanks for the hopium before the copium.
All you naysayers, just wait till FDA approves RDN in August. Everybody with blood pressure over 130/90 will be lining up for the $12,000 procedure and the stock will climb like a rocket. Why wouldn't payers cover it since it's almost as effective as a generic diuretic!
Well Medtronic tries to be like Apple. Unlike Apple and competitors, Medtronic does not reinvest in R&D. Medtronic spends more money on product shows, conferences, and feeding surgeons steak and lobsters.
Probably because investors are realizing we have nothing truly innovative in our pipeline. We’ve just become another Apple of making reiterations of the same technology, but unlike Apple, we cannot compete with the competition. Don’t worry; Geoff can solve it with A.I. and new ideas from Hyderabad, India!
Don’t fall into the “woke go broke” bs. It’s just a distraction from the upper level management trying to squeeze every cent out of us. The real reason stocks are going down upper management wants to cut corners in quality; hence, all the recalls.
Totally agree with you dude @ewq+1o13QQ1H: “A new October surprise, RIF will help al lot, IMHO”. I hope the October RIF gets all the Woke Police and DEI People in the Net & gets the boots. The only stock might see some +movements.
@azd+1o13QQ1H
Well put. Geoff is spending way too much time chasing quick profits by cutting corners. He's going to leave with a golden parachute while Medtronic crumbles.
A new October surprise, RIF will help al lot, IMHO
Until Geoff is out of his role as CEO and stops obsessing over poor stock market performance, the stock will just keep on dropping. Put patients and employees first. Focus on innovation. He doesn't follow the company mission he claimed he would uphold. Disappointing.
Time to jump ship
A class action lawsuit about defibrillators did not help.
Our loser CEO was awarded 20 million?
He doesn’t deserve that…
Geoff was awarded $20 Mil call options in August. That’s a bullish indicator. Poor leadership, no technology roadmap, top heavy organization, quality issues, blah blah blah are strong headwinds.